Leading Infectious Disease Biomaterial Manufacturer

  • Copan FLOQSwab® and Liquid Control Products
    • Clinical Diagnostics,
    • Proficiency Programs,
    • Training, Verification and Development
  • Antigens for Diagnostic Test Manufacturers
  • Viral Transport Medium – DxTM™
VTM? – LEARN MORE

Microbix & BioGX Collaborate on real-time PCR Assays & Controls

Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels MISSISSAUGA, CANADA & BIRMINGHAM, ALABAMA, December 7,...
Read More

Microbix Announces Initiation of Normal Course Issuer Bid

For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 6, 2023 - Microbix Biosystems Inc. (TSX: MBX,...
Read More

Microbix Presenting at Florida Capital Event Conference

Meetings with Growth-Oriented Investors, November 17 to 19, 2023 MISSISSAUGA, CANADA, November 17, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Read More

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.

               
  INVESTORS
 LEGAL
 CONTACT BLOG DOWNLOAD CATALOGUE